Dónde está registrado
Cada registro con su número de medicamentos y algunos de ellos.
Canadá
Health Canada · 27 medicamentos
- Tri-Cira 210.035 MG + 0.035 MG + 0.035 MG + 0.215 MG + 0.25 MG + 0.18 MG · Tablet · Apotex INC
- Tri-Cira 280.035 MG + 0.035 MG + 0.035 MG + 0.215 MG + 0.18 MG + 0.25 MG · Tablet · Apotex INC
- Tri-Cira Lo 210.025 MG + 0.025 MG + 0.025 MG + 0.215 MG + 0.25 MG + 0.18 MG · Tablet · Apotex INC
- Tri-Cira Lo 280.025 MG + 0.025 MG + 0.025 MG + 0.215 MG + 0.25 MG + 0.18 MG · Tablet · Apotex INC
Estados Unidos
FDA · 24 medicamentos
- Estarylla0.035MG; 0.25MG · tablet · Xiromed
- Mili0.035MG; 0.25MG · tablet · Aurobindo Pharma LTD
- Mono-Linyah0.035MG; 0.25MG · tablet · Novast Labs LTD
- Norgestimate and Ethinyl Estradiol0.025MG,0.025MG,0.025MG; 0.18MG,0.215MG,0.25MG, 0.035MG,0.035MG,0.035MG; 0.18MG,0.215MG,0.25MG, 0.035MG; 0.25MG · tablet · Lupin
Italia
AIFA · 8 medicamentos
Todos los medicamentos con Norgestimate
Todos los registros, página a página. Las dosis y los envases están en la página de cada medicamento.
26 resultados
| Medicamento | Registro | Dosis | Forma | Estado | Titular |
|---|---|---|---|---|---|
| Norgestimate; Ethinyl EstradiolCombinación | Estados Unidos | 0.215MG; 0.025MG, 0.215MG; 0.035MG, 0.25MG; 0.025MG … | tablet | Comercializado | Glenmark Pharms LTD |
| Norgestimate and Ethinyl EstradiolCombinación | Estados Unidos | 0.025MG,0.025MG,0.025MG; 0.18MG,0.215MG,0.25MG, 0.035MG,0.035MG,0.035MG; 0.18MG,0.215MG,0.25MG, 0.035MG; 0.25MG | tablet | Comercializado | Lupin |
| EstaryllaCombinación | Estados Unidos | 0.035MG; 0.25MG | tablet | Comercializado | Xiromed |
| Tri-EstaryllaCombinación | Estados Unidos | 0.035MG,0.035MG,0.035MG; 0.18MG,0.215MG,0.25MG | tablet | Comercializado | Xiromed |
| Tri-Lo-EstaryllaCombinación | Estados Unidos | 0.025MG,0.025MG,0.025MG; 0.18MG,0.215MG,0.25MG | tablet | Comercializado | Xiromed |
| Estradiol and NorgestimateCombinación | Estados Unidos | 1MG,1MG; 0.09MG | tablet | No comercializado | Barr |
| MiliCombinación | Estados Unidos | 0.035MG; 0.25MG | tablet | Comercializado | Aurobindo Pharma LTD |
| Mono-LinyahCombinación | Estados Unidos | 0.035MG; 0.25MG | tablet | Comercializado | Novast Labs LTD |
| SprintecCombinación | Estados Unidos | 0.035MG; 0.25MG | tablet | Comercializado | Barr |
| Tri-LinyahCombinación | Estados Unidos | 0.035MG,0.035MG,0.035MG; 0.18MG,0.215MG,0.25MG | tablet | Comercializado | Novast Labs LTD |
| Tri-Lo-MiliCombinación | Estados Unidos | 0.025MG,0.025MG,0.025MG; 0.18MG,0.215MG,0.25MG | tablet | Comercializado | Aurobindo Pharma |
| Tri Lo SprintecCombinación | Estados Unidos | 0.025MG,0.025MG,0.025MG; 0.18MG,0.215MG,0.25MG | tablet | Comercializado | Barr Labs INC |
| Tri-MiliCombinación | Estados Unidos | 0.035MG,0.035MG,0.035MG; 0.18MG,0.215MG,0.25MG | tablet | Comercializado | Aurobindo Pharma LTD |
| Tri-SprintecCombinación | Estados Unidos | 0.035MG,0.035MG,0.035MG; 0.18MG,0.215MG,0.25MG | tablet | Comercializado | Barr |
| Ortho Tri-Cyclen 21Combinación | Estados Unidos | 0.035MG,0.035MG,0.035MG; 0.18MG,0.215MG,0.25MG | tablet | Comercializado | Ortho Mcneil Pharm |
| Ortho Tri-Cyclen 28Combinación | Estados Unidos | 0.035MG,0.035MG,0.035MG; 0.18MG,0.215MG,0.25MG | tablet | Comercializado | Ortho Mcneil Pharm |
| Tri-Lo-LinyahCombinación | Estados Unidos | 0.025MG,0.025MG,0.025MG; 0.18MG,0.215MG,0.25MG | tablet | Comercializado | Novast Labs |
| Tri-Lo-LinyahCombinación | Estados Unidos | 0.215MG; 0.025MG, 0.25MG; 0.025MG | tablet | Aprobación provisional | Novast Labs |
| Ortho Cyclen-21Combinación | Estados Unidos | 0.035MG; 0.25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | tablet | No comercializado | Janssen Pharms |
| Ortho Cyclen-28Combinación | Estados Unidos | 0.035MG; 0.25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | tablet | No comercializado | Janssen Pharms |
| Ortho Tri-CyclenCombinación | Estados Unidos | 0.035MG,0.035MG,0.035MG; 0.18MG,0.215MG,0.25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | tablet | No comercializado | Janssen Pharms |
| Ortho Tri-CyclenCombinación | Estados Unidos | 0.035MG,0.035MG,0.035MG; 0.18MG,0.215MG,0.25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | tablet | No comercializado | Janssen Pharms |
| Ortho Tri-Cyclen LoCombinación | Estados Unidos | 0.025MG,0.025MG,0.025MG; 0.18MG,0.215MG,0.25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | tablet | No comercializado | Janssen Pharms |
| PrevifemCombinación | Estados Unidos | 0.035MG; 0.25MG | tablet | No comercializado | PH Health |
| Tri-PrevifemCombinación | Estados Unidos | 0.035MG,0.035MG,0.035MG; 0.18MG,0.215MG,0.25MG | tablet | No comercializado | PH Health |
Marcas
La misma marca en varios registros.
- Previfem🇨🇦 🇺🇸 · 2 registros
- Ortho Cyclen-21🇺🇸 · 1 registro
- Briladona🇮🇹 · 1 registro
- Centrisa 21🇨🇦 · 1 registro
- Effimia🇮🇹 · 1 registro
- Cyclen Tablets (21 Day)🇨🇦 · 1 registro
- Sarensis 21🇨🇦 · 1 registro
- Cilest Tab🇸🇦 · 1 registro
- EDELSIN comprimidos🇪🇸 · 1 registro
- Edelsine 0,250/0,035 MG Comprimidos🇪🇸 · 1 registro
- Estarylla🇺🇸 · 1 registro
- Liberelle 0,25 MG/0,035 MG Comprimidos Efg🇪🇸 · 1 registro
- Mili🇺🇸 · 1 registro
- Mono-Linyah🇺🇸 · 1 registro
Laboratorios
Los laboratorios titulares de sus medicamentos, primero los mayores.
A menudo combinado con
Principios activos con los que comparte medicamento.
Nombres en los registros
Cómo lo escriben los registros, en su propio idioma.
- Norgestimaat
- Norgestimato
Fuentes
Recopilado por Prognia a partir de los registros públicos de medicamentos de AEMPS, AIFA, Anvisa, CBG-MEB, FDA, Health Canada, SFDA y TFDA. La página de cada medicamento indica su propia fuente, licencia y atribución.
Notificar un error o solicitar la retiradaLas correcciones de un registro o un laboratorio son bienvenidas.
Para consulta y aprendizaje, no es una recomendación de tratamiento. Consulta siempre la información oficial del producto.
De un vistazo
- Registros
- 8
- Medicamentos
- 67
- Laboratorios
- 29